To view this email as a web page, click here.
Conference Coverage
 
 October 31, 2018
 
Today, we take a look back at the annual Residents Meeting of the National Psoriasis Foundation which took place earlier this month in Chicago. In these stories, we address important issues dermatology residents should explore. Visit our conference page for more.
 
Measuring psoriasis severity: Mostly clear or clear?
Understanding measures of psoriasis disease severity is critical for the patient. And, many payers, including the Centers for Medicare and Medicaid Service require an accurate PASI or PGA score on all psoriasis claims.
 
Let’s take a second look at traditional therapies for psoriasis
Biologics certainly have shown to be an effective treatment in plaque psoriasis, but physicians should not discount more traditional therapies for treating psoriasis.
 
The multifaceted faces of arthritis in psoriasis
For psoriasis patients, the most common comorbidity they may experience is psoriatic arthritis. Knowing how to identify and treat it can be critical.
 
Treat the whole patient in psoriasis
From obesity to heart disease, patients with psoriasis have a host of comorbidities and most rely on their dermatologist for comprehensive care.
 
Treatment options for psoriasis during adolescence
Developing psoriasis during childhood or adolescence can affect self-esteem. Dr. Amy Paller discussed the impact of psoriasis on adolescents, and treatment options, during the annual NPR Residents Meeting.
 
Making the right topical treatment choice in psoriasis
Nearly 80 percent of patients experience limited-to-moderate psoriasis disease, and topical therapies account for the majority, if not all, of their treatment. But the choice of topical treatment depends on the patient.
 
Phototherapy less utilized in practice, but still effective
At the 20th annual National Psoriasis Foundation residents meeting recently held in Chicago, Dr. Abby Van Voorhees, said that phototherapy can improve psoriasis, but it is not in common practice today.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.